160 related articles for article (PubMed ID: 24289130)
1. A review of epigenetic and gene expression alterations associated with intracranial meningiomas.
He S; Pham MH; Pease M; Zada G; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2013 Dec; 35(6):E5. PubMed ID: 24289130
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
Barski D; Wolter M; Reifenberger G; Riemenschneider MJ
Brain Pathol; 2010 May; 20(3):623-31. PubMed ID: 19922547
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic alterations in meningiomas.
Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
[TBL] [Abstract][Full Text] [Related]
4. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
7. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
10. Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Harmancı AS; Youngblood MW; Clark VE; Coşkun S; Henegariu O; Duran D; Erson-Omay EZ; Kaulen LD; Lee TI; Abraham BJ; Simon M; Krischek B; Timmer M; Goldbrunner R; Omay SB; Baranoski J; Baran B; Carrión-Grant G; Bai H; Mishra-Gorur K; Schramm J; Moliterno J; Vortmeyer AO; Bilgüvar K; Yasuno K; Young RA; Günel M
Nat Commun; 2017 Feb; 8():14433. PubMed ID: 28195122
[TBL] [Abstract][Full Text] [Related]
11. Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas.
Chang X; Shi L; Gao F; Russin J; Zeng L; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Wang K; Mack WJ
Neurosurg Focus; 2013 Dec; 35(6):E3. PubMed ID: 24289128
[TBL] [Abstract][Full Text] [Related]
12. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations associated with progression and recurrence in meningiomas.
Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B
J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of meningiomas: from basic research to potential clinical applications.
Simon M; Boström JP; Hartmann C
Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of brain meningiomas.
Byvalsev VA; Stepanov IA; Belykh EG; Yarullina AI
Patol Fiziol Eksp Ter; 2017; 61(2):82-91. PubMed ID: 29215848
[TBL] [Abstract][Full Text] [Related]
17. Histological classification and molecular genetics of meningiomas.
Riemenschneider MJ; Perry A; Reifenberger G
Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
[TBL] [Abstract][Full Text] [Related]
18. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
19. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
20. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
